According to dermatologists - skin specialists and endocrinologists - iron specialists at the University of Verona in Verona, Italy, the condition of skin psoriasis increases the risk of developing metabolic syndrome. Their report was published in January and February 2018. Journal of Clinical Dermatology.
Psoriasis is a non-contagious skin disorder in which skin cells divide too quickly and are lost on white or transparent scales. Metabolic syndrome is similar to type 2 diabetes.
Signs and symptoms of psoriasis include ...
- raised, red swollen skin spots,
- white scales,
- itch
- pain and
- dry, cracked skin that may bleed.
- Type 2 diabetes,
- mild insulin resistance
- belly fat
- high blood pressure,
- abnormal blood fats and
- non-alcoholic fatty liver disease.
Cortisone is one of the traditional treatments for psoriasis, but it can raise blood sugar levels. According to experts in Verona, biological products are safer. Treatment of patients with psoriasis with low-calorie diets and exercise is recommended to achieve and / or maintain a healthy lean weight.
Another type of medication recommended by the dermatologists of Verona is biology. Psoriasis is caused by autoimmunity, in which the immune system attacks the body. Biologicals help calm the immune system ...
- Patients should stop taking medication if they become infected, such as a cold.
- a flu shot every year is a good idea for people with psoriasis who take one of the biologicals, and a good idea for everyone else.
- adalimumab (Humira),
- brodalumab (siliq)
- etanercept (enbrel)
- golimumab (simponi)
- Infliximab (Remicade),
- ixekizumab (Taltz)
- secukinumab (Cosentyx) and
- ustekinumab (Stelara).
- Enbrel, Simponi, Remicade and Humira interact with alpha-alpha-TNF or tumor necrosis factor. TNF alpha is a proinflammatory cytokine, a protein that causes inflammation. It is secreted mainly by monocytes and macrophages, leukocytes, which produce inflammatory reactions. It is also built to some extent with the help of leukocytes, called lymphocytes, blood vessel cells and fibroblasts, cells that cause blood to clot.
- Siliq, Cosentyx and Taltz, blocking human interleukin 17, another inflammatory molecule.
- Stelara blocks inflammatory molecules of interleukin-22 and interleukin 23.
